Abstract
Vascular endothelial growth factor (VEGF) is an endothelial specific growth factor that can induce blood vessel formation. The patent claims the identification of three novel isoforms of VEGF-A, namely VEGF-A138, VEGF-A162 and VEGF-A182. These novel isoforms are discussed for their potential use in the treatment of cardiovascular diseases.